Buscar
Mostrando ítems 81-90 de 2368
Non-alcoholic Fatty Liver Disease prevalence in Latin America: A systematic review and meta-analysis.
(Elsevier, 2022)
Non-alcoholic fatty liver disease (NAFLD) produces high morbidity and mortality rates. Its worldwide prevalence is 25%, but evidence from Latin America (LA) is lacking. We aimed to estimate the prevalence of NAFLD in the ...
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas
(Elsevier, 2022)
Non-alcoholic fatty liver disease (NAFLD) affects 20–25% of the general population and is associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD risk factors are modifiable and, therefore, ...
Nonalcoholic fatty liver disease
(Macmillan Publishers, 2015-12)
Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are additional findings of portal and ...
Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women
(Informa Healthcare, 2014)
Fatty Liver Is Associated with Transcriptional Downregulation of Stearoyl-CoA Desaturase and Impaired Protein Dimerization
(Public Library Science, 2013-09-30)
AIMS AND METHODS: We evaluated the modulation of liver stearoyl-CoA desaturase-1 (Scd1) by dietary factors and insulin resistance (IR) in two experimental models of high-fat diet (HFD)-induced nonalcoholic fatty liver ...
Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study
(MEXICAN ASSOC HEPATOLOGY, 2012)
Introduction. Steatotic livers have been associated with greater risk of allograft dysfunction in liver transplantation. Our aim was to determinate the prevalence of steatosis in grafts from deceased donors in Chile and ...
Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients
(2006)
The aim of the present study was to test the hypothesis that induction of cytochrome P450 2E1 (CYP2E1) in the liver of patients with non-alcoholic fatty liver disease (NAFLD) is correlated both with the in vivo activity ...